Legend Biotech (LEGN) Change in Account Payables (2020 - 2025)

Legend Biotech's Change in Account Payables history runs 6 years deep, the most recent figure standing at $24.3 million for Q3 2025.

• Quarterly Change in Account Payables rose 289.32% year-over-year to $24.3 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $66.3 million (up 350.74% YoY) and the FY2024 annual result came in at $14.1 million, up 128.01% from the prior year.
• Change in Account Payables was $24.3 million for Q3 2025 at Legend Biotech, up from $16.5 million in the prior quarter.
• Across five years, Change in Account Payables topped out at $41.9 million in Q4 2022 and bottomed at -$34.5 million in Q4 2023.
• A 5-year average of $5.2 million and a median of $2.5 million in 2022 frame the typical range for Change in Account Payables.
• Annual changes were most pronounced in 2022 — Change in Account Payables jumped 4178.72% — and 2023, when it plunged 430.02%.
• Legend Biotech's Change in Account Payables stood at -$4.6 million in 2021, then surged by 1021.8% to $41.9 million in 2022, then sank by 182.21% to -$34.5 million in 2023, then soared by 117.51% to $6.0 million in 2024, then jumped by 302.04% to $24.3 million in 2025.
• Business Quant data shows LEGN's Change in Account Payables at $24.3 million in Q3 2025, $16.5 million in Q2 2025, and $19.5 million in Q1 2025.